3D model is for representation purpose only.
.
.
![]() |
![]() |
![]() |
![]() |
![]() |
|---|---|---|---|---|
| GGGGG | propyl | Camptothecin |
| Identification | |
|---|---|
| ConjuPepDB ID | cpd01535 |
| Smiles | |
| Molecular weight | 706.271 |
| Molecular formula | C33H38N8O10 |
| Chemical name | Peptide information |
| Sequence (one letter) | GGGGG |
| Length | 5 |
| Peptide name | oligoglycin |
| External ID | |
|---|---|
| CAS number | 330808-07-6 |
| Other information | |
|---|---|
| Application | Synthesis |
| Pharmacological class | anticancer |
| Conjugate type | amide |
| Linker | N/A |
| Linker Type | propyl |
| Small molecule | Camptothecin |
| Small molecule CAS | 7689-03-04 |
| Calculated properties | |
|---|---|
| LogP | -5.20087 |
| Rotatable bonds | 15 |
| H bond donor | 7 |
| H bond acceptor | 11 |
| Polar surface area (PSA) | 260.48000 |
| Citations | |||||
|---|---|---|---|---|---|
| ID | Title | Year | Authors | Journal | DOI |
Determinants for the drug release from T-0128, camptothecin analog-carboxymethyl dextran conjugate | 2000 | Harada, M.; Sakakibara, H.; Yano, T.; Suzuki, T.; Okuno, S. | Journal of Controlled Release | ||